These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 2153235)

  • 1. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
    Shin CG; Snapka RM
    Biochemistry; 1990 Dec; 29(49):10934-9. PubMed ID: 2176889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P; Moss T
    Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.
    Schaak J; Schedl P; Shenk T
    Nucleic Acids Res; 1990 Mar; 18(6):1499-508. PubMed ID: 2158079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei.
    Vilarem MJ; Riou JF; Multon E; Gras MP; Larsen CJ
    Biochem Pharmacol; 1986 Jul; 35(13):2087-95. PubMed ID: 3015146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase I and II activities are required for Epstein-Barr virus replication.
    Kawanishi M
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2263-8. PubMed ID: 8409949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro.
    Ishimi Y; Ishida R; Andoh T
    Mol Cell Biol; 1992 Sep; 12(9):4007-14. PubMed ID: 1324412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks.
    Singh S; Szlachta K; Manukyan A; Raimer HM; Dinda M; Bekiranov S; Wang YH
    J Biol Chem; 2020 Mar; 295(12):3990-4000. PubMed ID: 32029477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
    Tewey KM; Chen GL; Nelson EM; Liu LF
    J Biol Chem; 1984 Jul; 259(14):9182-7. PubMed ID: 6086625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
    Riou JF; Grondard L; Naudin A; Bailly C
    Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
    Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
    Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
    Perrin D; van Hille B; Barret JM; Kruczynski A; Etiévant C; Imbert T; Hill BT
    Biochem Pharmacol; 2000 Apr; 59(7):807-19. PubMed ID: 10718339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE; Rowe TC
    Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
    Holm C; Covey JM; Kerrigan D; Pommier Y
    Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
    Stevnsner T; Bohr VA
    Carcinogenesis; 1993 Sep; 14(9):1841-50. PubMed ID: 8403208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.